Cell line and drug

Publication Title Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia.
DOI https://doi.org/10.1016/j.prp.2019.152494
Year 2019
 
 
Please select
 
 
miRNA ID
Trait, Trait subtype
Cell Line
Drug 1
Drug 2
Drug 3
  
MIMAT0026478 Acute Lymphoblastic Leukemia (ALL), T-ALL KOPT-K1 Rapamycin Not Applicable Not Applicable
MIMAT0026478 Acute Lymphoblastic Leukemia (ALL), T-ALL Jurkat Rapamycin Not Applicable Not Applicable
MIMAT0026478 Acute Lymphoblastic Leukemia (ALL), T-ALL CCRF-CEM Rapamycin Not Applicable Not Applicable
MIMAT0022502 Acute Lymphoblastic Leukemia (ALL), T-ALL KOPT-K1 Rapamycin Not Applicable Not Applicable
MIMAT0022502 Acute Lymphoblastic Leukemia (ALL), T-ALL Jurkat Rapamycin Not Applicable Not Applicable
MIMAT0022502 Acute Lymphoblastic Leukemia (ALL), T-ALL CCRF-CEM Rapamycin Not Applicable Not Applicable
MI0005769 Acute Lymphoblastic Leukemia (ALL), T-ALL KOPT-K1 Rapamycin Not Applicable Not Applicable
MI0005769 Acute Lymphoblastic Leukemia (ALL), T-ALL Jurkat Rapamycin Not Applicable Not Applicable
MI0005769 Acute Lymphoblastic Leukemia (ALL), T-ALL CCRF-CEM Rapamycin Not Applicable Not Applicable
Count 9